Objective To compare the differences of quality of life ( QOL) between self-rating report and guardian′ report through evaluating and describing the QOL of minors with malignant bone tumors. Methods Totally 68 cases of minors with malignant bone tumors hospitalized in Peking Union Medical College Hospital and their parents were selected from October 2012 to October 2015, and were investigated by PedsQL 4.0 scale and PedsQL 3. 0 scale to collect the QOL of minors evaluated by patients and their parents. Results The overall QOL of minors with malignant bone tumors was at a low level. The results of QOL of parents′evaluation were consistent with the results of self-evaluation of minors ( P>0.05) . However, the scores of self-evaluation in physiology, pain, nausea and vomiting, operational anxiety, anxiety of treatment and worries were higher than those of results of parents′ evaluation (P<0.05), and the score of school function of self-evaluation was lower than that of parents′ evaluation ( P<0. 05 ) . Conclusions As for the QOL that evaluated by minors and parents, when the minors have difficulties in self-evaluation, the parents′ report has some reference value. As a individual, the QOL from minors themselves and from parents may be different, so in clinical work, we should provide comprehensive personized and high-quality nursing based on the fully combination of minors self-evaluation and parents′report.

Objective:To evaluate the potential effects of serum lipid levels, appendicular skeletal muscle mass index (ASMI) and body mass index (BMI), together with its dynamic changes, on tumor progression in renal clear cell carcinoma patients, so as to inform body weight management.Methods:This prospective cohort study included a total of 100 patients with high-risk clear cell renal cell carcinoma. Serum lipid levels were detected, ASMI and BMI were measured using bioelectrical impedance analysis and the dynamic changes of BMI were tracked. The effects of BMI, ASMI and serum lipid levels on tumor progression within 2 years were explored.Results:Patients with normal BMI and low ASMI had 5.248 (95% CI: 1.946 to 14.153, P = 0.001) times higher risk of tumor progression than those who were overweight or obese. For every 0.1-unit increase in pre-operative HDL-C, the risk of tumor progression decreased by 0.771 (95% CI: 0.631 to 0.942, P = 0.011) times. Patients who experienced more than 5% decrease in BMI compared with baseline had 5.165 (95% CI: 1.735 to 15.370, P = 0.003) times the progression risk of patients whose BMI changed within ±5% from baseline. Conclusions:The advantage of obese clear cell carcinoma patients over normal-weight patients in tumor progression-free survival may be influenced by ASMI, pre-onset involuntary weight loss and lipid levels. Therefore, patient weight management should not merely focus on absolute BMI but tailor to individual characteristics, including cancer stage, body composition and metabolic status.